Responsible development of clinical speech AI: Bridging the gap between clinical research and technology

Visar Berisha, Julie M. LissNpj Digit. Medicine 2024 · DOI

TL;DR

This paper argues for a more responsible and integrated approach to developing AI for clinical speech analysis. By bridging the gap between speech science and clinical research, we can create more interpretable, robust, and clinically useful AI models, especially when dealing with limited clinical datasets.

What Problem Does This Paper Address?

The paper tackles the significant challenge of developing effective AI models for clinical speech analysis, particularly in the context of limited, small, and often retrospectively collected clinical datasets. While AI has shown promise in areas like automatic speech recognition (ASR) with vast datasets, clinical applications face a data scarcity problem. Existing models often rely on high-dimensional features and data-driven approaches that can lead to overfitting and poor generalization to new data. Furthermore, these models frequently lack interpretability and robustness, making them difficult to troubleshoot or improve. The authors highlight that the complexity of speech production and the variability in how health conditions manifest make it challenging to build reliable diagnostic models solely on data-driven methods. They propose a framework to better understand the relationship between health conditions and speech, aiming to reduce the complexity of AI models and accelerate their translation into clinical practice.

Methods

The authors propose a framework for organizing health conditions based on their impact on the speech production mechanism, categorizing them into zeroth, first, second, and third-order impacts. This hierarchy aims to provide a structured way to understand the complexity of speech alterations associated with different diseases. They advocate for co-designing analytics pipelines that integrate insights from speech science and clinical research into existing supervised models. This approach aims to reduce sample complexity, improve interpretability, and potentially decrease timelines to translation. The paper also emphasizes the importance of moving beyond cross-sectional classification to explore other contexts of use for speech analytics, such as diagnostic assistance, non-specific risk assessment, longitudinal tracking, and as a meaningful endpoint in clinical trials and digital therapeutics. They stress the need for explainable and individually-validated measures, moving away from high-dimensional, uninterpretable features.

Datasets

Not discussed in the paper. The paper is a perspective piece and does not present new experimental results or datasets. It discusses the challenges associated with existing clinical datasets.

Key Insights and Ideas

  • The "data problem" in clinical speech AI is multifaceted: It's not just about the quantity of data, but also the quality of diagnostic labels, the variability of symptoms, and the inherent complexity of speech production.
  • Integrating speech science is crucial: Leveraging decades of research on how the brain and body produce speech can inform AI model development, making them more efficient and interpretable, especially with limited data.
  • A hierarchical approach to health conditions: Understanding how directly a condition impacts speech production (from physical structures to cognitive processes) can guide model development and set realistic expectations for performance.
  • Beyond diagnosis: Speech AI has potential in various clinical contexts, including risk assessment, monitoring disease progression, and serving as a meaningful endpoint in trials, which can accelerate translation.
  • Explainability and individual validation are key: Moving away from "black box" models towards interpretable features and individually validated measures is essential for trust, troubleshooting, and clinical utility.

Key Results

Not applicable, as this is a perspective piece and does not present experimental results.

Limitations and Future Work

The authors acknowledge that their proposed framework is a starting point and needs to be instantiated for specific clinical applications. They highlight that the development of clinically-tailored, interpretable speech representations is still a significant challenge. Future work should focus on:

  • Operationalizing and validating interpretable measures: Developing standardized definitions and validation methods for speech constructs relevant to clinical conditions.
  • End-to-end validation: Implementing a comprehensive validation framework (like the V3 framework) that includes hardware verification, analytical validation, and clinical validation.
  • Addressing data bias: Diversifying training data to ensure models work well across underrepresented groups and languages.
  • Ethical considerations: Prioritizing robust validation, transparency, and responsible communication to mitigate risks associated with premature deployment and biased models.
  • Exploring diverse contexts of use: Expanding the application of speech AI beyond simple classification to areas like longitudinal monitoring and clinical trial endpoints.

Summary updated

BibTeX
@article{berisha2024responsible,
  author = {Visar Berisha and Julie M. Liss},
  title = {{Responsible development of clinical speech AI: Bridging the gap between clinical research and technology}},
  journal = {Npj Digit. Medicine},
  year = {2024},
  doi = {10.1038/s41746-024-01199-1},
}
Figure